Literature DB >> 1682653

One week eradication regimen for Helicobacter pylori.

R P Logan1, P A Gummett, J J Misiewicz, Q N Karim, M M Walker, J H Baron.   

Abstract

Although Helicobacter pylori is both a frequent cause of gastritis and an important factor in duodenal ulcer recurrence, no treatment regimen exists that is completely safe and effective. We have studied a short eradication regimen of tripotassium dicitrato bismuthate 120 mg four times daily and amoxycillin 500 mg four times daily for seven days with metronidazole 400 mg five times daily for three days (days 5-7). 106 patients with peptic ulceration and non-ulcer dyspepsia, who were also infected with H pylori, were entered into the study. H pylori was successfully eradicated in 76/106 (72%) patients (median follow-up 9.3 months). The rate of eradication was higher among patients with metronidazole-sensitive H pylori (40/43, 93%). In 17/30 patients in whom eradication failed, pretreatment metronidazole-resistant strains were subsequently isolated. Side-effects were mild, the commonest (24/106, 24%) being taste disturbance with metronidazole. A one-week eradication regimen is a safe, effective, cheap, and well-tolerated treatment for metronidazole-sensitive H pylori.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682653     DOI: 10.1016/0140-6736(91)92111-e

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  29 in total

1.  Pharmacodynamic effects of nitroimidazoles alone and in combination with clarithromycin on Helicobacter pylori.

Authors:  Margareta Svensson; Lennart E Nilsson; Magnus Ström; Maud Nilsson; Mikael Sörberg
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

Review 2.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

Review 3.  ERBBs in the gastrointestinal tract: recent progress and new perspectives.

Authors:  William H Fiske; David Threadgill; Robert J Coffey
Journal:  Exp Cell Res       Date:  2008-11-07       Impact factor: 3.905

Review 4.  The 13C urea breath test in the diagnosis of Helicobacter pylori infection.

Authors:  V Savarino; S Vigneri; G Celle
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

5.  Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains.

Authors:  A A van Zwet; J C Thijs; B de Graaf
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

6.  Insertion of mini-IS605 and deletion of adjacent sequences in the nitroreductase (rdxA) gene cause metronidazole resistance in Helicobacter pylori NCTC11637.

Authors:  Y J Debets-Ossenkopp; R G Pot; D J van Westerloo; A Goodwin; C M Vandenbroucke-Grauls; D E Berg; P S Hoffman; J G Kusters
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

7.  Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori.

Authors:  M Sörberg; H Hanberger; M Nilsson; A Björkman; L E Nilsson
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

8.  High Helicobacter pylori numbers are associated with low eradication rate after triple therapy.

Authors:  M Moshkowitz; F M Konikoff; Y Peled; M Santo; A Hallak; Y Bujanover; E Tiomny; T Gilat
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

9.  One week's anti-Helicobacter pylori treatment for duodenal ulcer.

Authors:  R P Logan; P A Gummett; J J Misiewicz; Q N Karim; M M Walker; J H Baron
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

10.  One-day therapy for treatment of Helicobacter pylori infection.

Authors:  A Tucci; R Corinaldesi; V Stanghellini; G F Paparo; S Gasperoni; G Biasco; O Varoli; M Ricci-Maccarini; L Barbara
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.